Clinical predictors of malignant transformation and recurrence in oral potentially malignant disorders: A systematic review and meta-analysis

Imagem de Miniatura
Arquivos
art_PAGLIONI_Clinical_predictors_of_malignant_transformation_and_recurrence_in_2022.PDF (1.79 MB)
Citações na Scopus
1
Tipo de produção
article
Data de publicação
2022
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
ELSEVIER SCIENCE INC
Autores
PAGLIONI, Mariana de Pauli
KHURRAM, Syed Ali
RUIZ, Blanca Iciar Indave
LAUBY-SECRETAN, Beatrice
NORMANDO, Ana Gabriela
RIBEIRO, Ana Carolina Prado
PALMIER, Natalia Rangel
LOPES, Marcio Ajudarte
GUERRA, Eliete Neves da Silva
Citação
ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY, v.134, n.5, p.573-587, 2022
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Objective. We performed a systematic review dedicated to pooling evidence for the associations of clinical features with malignant transformation (MT) and recurrence of 3 oral potentially malignant disorders (OPMDs) (actinic cheilitis [AC], oral leukoplakia [OL], and proliferative verrucous leukoplakia [PVL]). Study Design. We selected studies that included clinical features and risk factors (age, sex, site, size, appearance, alcohol intake, tobacco use, and sun exposure) of OL, PVL, and AC associated with recurrence and/or MT. Results. Based on the meta-analysis results, non-homogeneous OL appears to have a 4.53 times higher chance of recurrence after treatment. We also found 6.52 higher chances of MT of non-homogeneous OL. Another clinical feature related to higher MT chances is the location (floor of the mouth and tongue has 4.48 higher chances) and the size (OL with >200 mm2 in size has 4.10 higher chances of MT). Regarding habits, nonsmoking patients with OL have a 3.20 higher chance of MT. The only clinical feature related to higher chances of MT in patients with PVL was sex (females have a 2.50 higher chance of MT). Conclusions. Our study showed that some clinical features may indicate greater chances of recurrence after treatment and MT of OPMD.
Palavras-chave
URI
https://observatorio.fm.usp.br/handle/OPI/53761
Referências
  1. Abadie WM, 2015, OTOLARYNG HEAD NECK, V153, P504, DOI 10.1177/0194599815586779
  2. Arduino PG, 2009, J ORAL PATHOL MED, V38, P540, DOI 10.1111/j.1600-0714.2009.00782.x
  3. Bagan J, 2020, CLIN ORAL INVEST, V24, P1963, DOI 10.1007/s00784-019-03059-9
  4. Bagan J, 2019, J PERIODONTOL, V90, P1142, DOI [10.1002/WER.18-0620, 10.1002/JPER.18-0620]
  5. Bagan JV, 2011, ORAL ONCOL, V47, P732, DOI 10.1016/j.oraloncology.2011.05.008
  6. Balshem H, 2011, J CLIN EPIDEMIOL, V64, P401, DOI 10.1016/j.jclinepi.2010.07.015
  7. Barnes L., 2005, PATHOLOGY GENETICS H
  8. Braakhuis BJM, 2003, CANCER RES, V63, P1727
  9. Bremmer JF, 2011, ORAL ONCOL, V47, P956, DOI 10.1016/j.oraloncology.2011.07.025
  10. Brouns EREA, 2014, ORAL DIS, V20, pe19, DOI 10.1111/odi.12095
  11. Chaves YN, 2017, PHOTODERMATOL PHOTO, V33, P14, DOI 10.1111/phpp.12281
  12. Diajil A, 2013, INT J DENT, V2013, DOI 10.1155/2013/809248
  13. EINHORN J, 1967, CANCER, V20, P2189, DOI 10.1002/1097-0142(196712)20:12<2189::AID-CNCR2820201218>3.0.CO;2-M
  14. Gandara-Vila P, 2018, MED ORAL PATOL ORAL, V23, pE413, DOI 10.4317/medoral.22326
  15. Gandolfo S, 2009, J PERIODONTOL, V80, P274, DOI 10.1902/jop.2009.080329
  16. GANGADHARAN P, 1971, BRIT J CANCER, V25, P657, DOI 10.1038/bjc.1971.81
  17. Goodson ML, 2015, BRIT J ORAL MAX SURG, V53, P831, DOI 10.1016/j.bjoms.2015.08.268
  18. Gouvea AF, 2010, J ORAL PATHOL MED, V39, P447, DOI 10.1111/j.1600-0714.2010.00889.x
  19. GUPTA PC, 1989, CANCER-AM CANCER SOC, V63, P2247, DOI 10.1002/1097-0142(19890601)63:11<2247::AID-CNCR2820631132>3.0.CO;2-D
  20. HANSEN LS, 1985, ORAL SURG ORAL MED O, V60, P285, DOI 10.1016/0030-4220(85)90313-5
  21. Ho MW, 2012, ORAL ONCOL, V48, P969, DOI 10.1016/j.oraloncology.2012.04.002
  22. Ho PS, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-260
  23. Holmstrup P, 2006, ORAL ONCOL, V42, P461, DOI 10.1016/j.oraloncology.2005.08.011
  24. Iocca O, 2020, HEAD NECK-J SCI SPEC, V42, P539, DOI 10.1002/hed.26006
  25. Ishii J, 2003, ORAL ONCOL, V39, P759, DOI 10.1016/S1368-8375(03)00043-5
  26. Jayasooriya PR, 2020, CLIN ORAL INVEST, V24, P4563, DOI 10.1007/s00784-020-03322-4
  27. Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]
  28. Jerjes W, 2012, LASER MED SCI, V27, P169, DOI 10.1007/s10103-011-0916-z
  29. Kaugars GE, 1999, ORAL SURG ORAL MED O, V88, P181, DOI 10.1016/S1079-2104(99)70115-0
  30. Kuribayashi Y, 2012, J ORAL PATHOL MED, V41, P682, DOI 10.1111/j.1600-0714.2012.01167.x
  31. Lee JJ, 2006, ORAL SURG ORAL MED O, V101, P472, DOI 10.1016/j.tripleo.2005.07.024
  32. Liu Wei, 2010, BMC Cancer, V10, P685, DOI 10.1186/1471-2407-10-685
  33. Liu W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034773
  34. Liu W, 2011, J ORAL PATHOL MED, V40, P312, DOI 10.1111/j.1600-0714.2011.01016.x
  35. Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI [10.1002/14651858.CD001930.pub3, 10.1136/bmj.d5928]
  36. Markopoulos A, 2004, ORAL DIS, V10, P212, DOI 10.1111/j.1601-0825.2004.01004.x
  37. Maruccia M, 2012, ANTICANCER RES, V32, P1543
  38. Mehanna HM, 2009, HEAD NECK-J SCI SPEC, V31, P1600, DOI 10.1002/hed.21131
  39. MEHTA FS, 1981, J CANCER RES CLIN, V99, P35, DOI 10.1007/BF00412440
  40. Mello FW, 2018, J ORAL PATHOL MED, V47, P633, DOI 10.1111/jop.12726
  41. Mogedas-Vegara A, 2015, J CRANIO MAXILL SURG, V43, P677, DOI 10.1016/j.jcms.2015.03.011
  42. Mustafa MB, 2019, INT DENT J, V69, P428, DOI 10.1111/idj.12509
  43. Napier SS, 2003, ORAL DIS, V9, P129, DOI 10.1034/j.1601-0825.2003.02888.x
  44. OCZY JB, 1977, J MAXILLOFAC SURG, V5, P69
  45. Page MJ, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n160
  46. Pentenero M, 2011, J ORAL PATHOL MED, V40, P214, DOI 10.1111/j.1600-0714.2010.00984.x
  47. PINDBORG JJ, 1968, J AM DENT ASSOC, V76, P767, DOI 10.14219/jada.archive.1968.0127
  48. Reibel J, 2003, CRIT REV ORAL BIOL M, V14, P47, DOI 10.1177/154411130301400105
  49. Rubert Andrea, 2020, J Clin Exp Dent, V12, pe540, DOI 10.4317/jced.57091
  50. Saito T, 2001, INT J ORAL MAX SURG, V30, P49, DOI 10.1054/ijom.2000.0012
  51. Scheifele C, 2003, ORAL ONCOL, V39, P470, DOI 10.1016/S1368-8375(03)00006-X
  52. Schepman KP, 1998, ORAL ONCOL, V34, P270, DOI 10.1016/S1368-8375(98)80007-9
  53. Shin MN, 2000, BRIT J CANCER, V82, P1871, DOI 10.1054/bjoc.2000.1208
  54. Shiu MN, 2004, EUR J CANCER PREV, V13, P39, DOI 10.1097/00008469-200402000-00007
  55. SILVERMAN S, 1976, CANCER-AM CANCER SOC, V38, P1790, DOI 10.1002/1097-0142(197610)38:4<1790::AID-CNCR2820380456>3.0.CO;2-I
  56. Silverman S, 1997, ORAL SURG ORAL MED O, V84, P154, DOI 10.1016/S1079-2104(97)90062-7
  57. SILVERMAN S, 1984, CANCER, V53, P563
  58. Speight PM, 2018, OR SURG OR MED OR PA, V125, P612, DOI 10.1016/j.oooo.2017.12.011
  59. Starzynska A, 2014, POSTEP DERM ALERGOL, V31, P341, DOI 10.5114/pdia.2014.40932
  60. Sundberg J, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0225682
  61. The Joanna Briggs Institute, 2014, JOANN BRIGGS I REV M
  62. Thomson PJ, 2017, INT J ORAL MAX SURG, V46, P337, DOI 10.1016/j.ijom.2016.11.001
  63. Thomson PJ, 2018, J ORAL PATHOL MED, V47, P557, DOI 10.1111/jop.12716
  64. Torrejon-Moya A, 2020, J ORAL PATHOL MED, V49, P404, DOI 10.1111/jop.12999
  65. Upadhyaya JD, 2018, HEAD NECK PATHOL, V12, P500, DOI 10.1007/s12105-018-0893-7
  66. van der Hem PS, 2005, ORAL ONCOL, V41, P31, DOI 10.1016/j.oraloncology.2004.06.010
  67. van der Waal I, 2015, MED ORAL PATOL ORAL, V20, pE685, DOI 10.4317/medoral.21007
  68. van der Waal I, 2014, MED ORAL PATOL ORAL, V19, pE386, DOI 10.4317/medoral.20205
  69. van der Waal I, 2008, ORAL ONCOL, V44, P719, DOI 10.1016/j.oraloncology.2007.09.010
  70. van der Waal I, 2009, ORAL ONCOL, V45, P317, DOI 10.1016/j.oraloncology.2008.05.016
  71. Wang TJ, 2019, J ORAL PATHOL MED, V48, P491, DOI 10.1111/jop.12862
  72. Wang TY, 2018, J FORMOS MED ASSOC, V117, P374, DOI 10.1016/j.jfma.2018.01.017
  73. Warnakulasuriya S, 2007, J ORAL PATHOL MED, V36, P575, DOI 10.1111/j.1600-0714.2007.00582.x
  74. Warnakulasuriya S, 2016, J ORAL PATHOL MED, V45, P155, DOI [10.1111/jop.12267, 10.1111/jop.12339]
  75. Warnakulasuriya S, 2011, J ORAL PATHOL MED, V40, P677, DOI 10.1111/j.1600-0714.2011.01054.x
  76. Warnakulasuriya S, 2021, ORAL DIS, V27, P1862, DOI 10.1111/odi.13704
  77. Warnakulasuriya S, 2020, ORAL ONCOL, V102, DOI 10.1016/j.oraloncology.2019.104550
  78. Warnakulasuriya S, 2018, OR SURG OR MED OR PA, V125, P582, DOI 10.1016/j.oooo.2018.03.011
  79. Warnakulasuriya S, 2010, INT DENT J, V60, P7, DOI 10.1922/IDJ_2532Warnakulasuriya24
  80. Wu WY, 2019, J ORAL MAXIL SURG, V77, P2483, DOI 10.1016/j.joms.2019.08.002
  81. Yang SW, 2020, HEAD NECK-J SCI SPEC, V42, P1014, DOI 10.1002/hed.26074
  82. Yang SW, 2010, ORL-J OTO-RHIN-LARYN, V72, P280, DOI 10.1159/000318874
  83. Yen AMF, 2008, J ORAL PATHOL MED, V37, P417, DOI 10.1111/j.1600-0714.2008.00652.x

Coleções
Artigos e Materiais de Revistas Científicas - FM/MCG
Artigos e Materiais de Revistas Científicas - HC/ICESP
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - LIM/28